{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T14:10:49Z","timestamp":1776003049377,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Enteroglucagon refers to the predominant peptide with glucagon-like immunoreactivity (GLI) that is released by the intestine into the circulation in response to nutrients. Development of a radioimmunoassay for glucagon revealed issues that were not apparent in applications of the insulin radioimmunoassay. The fact that some antisera raised against glucagon recognized glucagon-related peptides in extracts of both pancreas and gut whereas others recognized only components in the pancreas remained a mystery until it was realized that the \u201cgut GLI cross-reactive\u201d antisera were directed against an epitope in the N-terminal to central region of glucagon whereas the \u201cpancreatic glucagon specific\u201d antisera were directed against an epitope in the C-terminal region. Unlike the cross-reactive antisera, the glucagon specific antisera did not recognize components in which glucagon was extended from its C-terminus by additional amino acids. Initial attempts to purify enteroglucagon from porcine ileum led to the erroneous conclusion that enteroglucagon comprised 100 amino acids with an apparent molecular mass of 12,000 Da and was consequently given the name glicentin. Subsequent work established that the peptide constituted residues (1-69) of proglucagon (M<jats:sub>r<\/jats:sub> 8128<jats:sub>)<\/jats:sub>. In the 40 years since the structural characterization of glicentin, attempts to establish an unambiguous physiological function for enteroglucagon have not been successful. Unlike the oxyntomodulin domain at the C-terminus of enteroglucagon, the primary structure of the N-terminal domain (glicentin-related pancreatic peptide) has been poorly conserved among mammals. Consequently, most investigations of the bioactivity of porcine glicentin may have been carried out in inappropriate animal models. Enteroglucagon may simply represent an inactive peptide that ensures that the intestine does not release equimolar amounts of a hyperglycemic agent (glucagon) and a hypoglycemic agent (GLP-1) after ingestion of nutrients.<\/jats:p>","DOI":"10.3389\/fendo.2021.683089","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:23:07Z","timestamp":1623410587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective"],"prefix":"10.3389","volume":"12","author":[{"given":"J. Michael","family":"Conlon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/304368a0","article-title":"Exon Duplication and Divergence in the Human Preproglucagon Gene","volume":"304","author":"Bell","year":"1983","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/14.12.4719","article-title":"Structure of the Human Glucagon Gene","volume":"14","author":"White","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97233","article-title":"Discovery, Characterization, and Clinical Development of the Glucagon-Like Peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c170055","article-title":"Glucagon-Like Peptide-2 and the Regulation of Intestinal Growth and Function","volume":"8","author":"Brubaker","year":"2018","journal-title":"Compr Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-Like Peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)85474-6","article-title":"Aqueous Extracts of Pancreas III. Some Precipitation Reactions of Insulin","volume":"58","author":"Kimball","year":"1923","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/diab.6.3.234","article-title":"The Amino Acid Sequence of Glucagon","volume":"6","author":"Bromer","year":"1957","journal-title":"Diabetes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(85)90203-4","article-title":"Primary Structure of Glucagon and a Partial Sequence of Oxyntomodulin (Glucagon-37) From the Guinea Pig","volume":"11","author":"Conlon","year":"1985","journal-title":"Regul Pept"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(72)80192-3","article-title":"The Amino Acid Sequence of Human Glucagon","volume":"21","author":"Thomsen","year":"1972","journal-title":"FEBS Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)57183-0","article-title":"Origin and Distribution of the Hyperglycemic-Glycogenolytic Factor of the Pancreas","volume":"175","author":"Sutherland","year":"1948","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104357","article-title":"Glucagon Antibodies and an Immunoassay for Glucagon","volume":"40","author":"Unger","year":"1961","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1172\/JCI103979","article-title":"Quantitative Aspects of the Reaction Between Insulin and Insulin-Binding Antibody","volume":"38","author":"Berson","year":"1959","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(66)90156-9","article-title":"Distribution of Immunoassayable Glucagon in Gastrointestinal Tissues","volume":"15","author":"Unger","year":"1966","journal-title":"Metabolism"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(66)92982-5","article-title":"Immunochemical Glucagon in Human Pancreas, Gut, and Plasma","volume":"2","author":"Samols","year":"1966","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1172\/JCI105714","article-title":"Characterization of the Responses of Circulating Glucagon-Like Immunoreactivity to Intraduodenal and Intravenous Administration of Glucose","volume":"47","author":"Unger","year":"1968","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/diab.19.9.614","article-title":"Characterization of Glucagon-Like Immunoreactivity (GLI)","volume":"19","author":"Valverde","year":"1970","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0026-0495(76)80134-5","article-title":"Structure-Function Relationship: Immunologic","volume":"25","author":"Heding","year":"1976","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/diab.21.8.843","article-title":"Structure-Function and Structure-Immunoreactivity Relationships of the Glucagon Molecule and Related Synthetic Peptides","volume":"21","author":"Assan","year":"1972","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0019-2791(72)90031-6","article-title":"The Immune Response to Glucagon in Conjugated Form","volume":"9","author":"Senyk","year":"1972","journal-title":"Immunochemistry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/BF00290482","article-title":"The Glucagon-Like Polypeptides - Order Out of Chaos","volume":"18","author":"Conlon","year":"1980","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-6-1090","article-title":"Presence of Glucagon Immunoreactivity in the Globulin Fraction of Human Plasma (\u201cBig Plasma Glucagon\u201d)","volume":"39","author":"Valverde","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(75)90095-5","article-title":"Heterogeneity of Plasma Glucagon Immunoreactivity in Normal, Depancreatized, and Alloxan-Diabetic Dogs","volume":"24","author":"Valverde","year":"1975","journal-title":"Metabolism"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(82)90002-1","article-title":"The Nature of Big Plasma Somatostatin: Implications for the Measurement of Somatostatin-Like Immunoreactivity in Human Plasma","volume":"125","author":"Conlon","year":"1982","journal-title":"Anal Biochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32125-0","article-title":"Immunochemical Studies of Macromolecular Gastrins: Evidence That \u201cBig, Big Gastrins\u201d Are Artifacts in Blood and Mucosa","volume":"73","author":"Rehfeld","year":"1977","journal-title":"Gastroenterology"},{"key":"B25","article-title":"Comparison of Methods of Separation of Free From Bound Hormone in the Radioimmunoassay of Insulin and Glucagon","volume-title":"Radioimmunoassay Methods","author":"Buchanan","year":"1971"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-1-84","article-title":"Mouse Salivary Glands Secrete a Glucagon-Degrading Enzyme, Not Glucagon","volume":"117","author":"Baldissera","year":"1985","journal-title":"Endocrinology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-196802000-00007","article-title":"Incubation Damage in the Radioimmunoassay for Human Plasma Glucagon and Its Prevention With \u201cTrasylol\u201d","volume":"255","author":"Eisentraut","year":"1968","journal-title":"Am J Med Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.8.2321","article-title":"Isolation of a Glucagon-Containing Peptide: Primary Structure of a Possible Fragment of Proglucagon","volume":"70","author":"Tager","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(82)80708-4","article-title":"Isolation of Glucagon-37 (Bioactive Enteroglucagon\/Oxyntomodulin) From Porcine Jejuno-Ileum. Isolation of the Peptide","volume":"146","author":"Bataille","year":"1982","journal-title":"FEBS Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2795(73)90153-0","article-title":"Isolation of Glucagon-Like Immunoreactivity of Gut by Affinity Chromatography on Anti-Glucagon Antibodies Coupled to Sepharose 4b","volume":"23","author":"Murphy","year":"1973","journal-title":"Biochim Biophys Acta"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1093615","article-title":"Purification and Characterization of a Protein From Porcine Gut With Glucagon-Like Immunoreactivity","volume":"8","author":"Sundby","year":"1976","journal-title":"Horm Metab Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2795(79)90026-6","article-title":"Physicochemical and Biological Properties of Glucagon-Like Polypeptides From Porcine Colon","volume":"577","author":"Conlon","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.7.700","article-title":"Glucagon-Like Polypeptides in Canine Brain","volume":"28","author":"Conlon","year":"1979","journal-title":"Diabetes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2795(77)90201-x","article-title":"Sequence Analysis of Porcine Gut GLI-1","volume":"493","author":"Jacobsen","year":"1977","journal-title":"Biochim Biophys Acta"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90297-2","article-title":"Orci L. Glicentin: A Precursor of Glucagon","volume":"25","author":"Ravazzola","year":"1979","journal-title":"Life Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/289514a","article-title":"Relationship of Glicentin to Proglucagon and Glucagon in the Porcine Pancreas","volume":"289","author":"Moody","year":"1981","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(81)90007-0","article-title":"The Primary Structure of Porcine Glicentin (Proglucagon)","volume":"2","author":"Thim","year":"1981","journal-title":"Regul Pept"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(82)90041-3","article-title":"Purification and Chemical Characterization of a Glicentin-Related Pancreatic Peptide (Proglucagon Fragment) From Porcine Pancreas","volume":"703","author":"Thim","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"B39","first-page":"50P","article-title":"The Effects of Pancreotone and Glucagon-Like Immunoreactivity on Pancreatic and Gastric Secretion","volume":"275","author":"Buchanan","year":"1978","journal-title":"J Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/gut.12.10.773","article-title":"Endocrine Tumour in Kidney Affecting Small Bowel Structure, Motility, and Absorptive Function","volume":"12","author":"Gleeson","year":"1971","journal-title":"Gut"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/gut.13.7.520","article-title":"An Enteroglucagon Tumour","volume":"13","author":"Bloom","year":"1972","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(81)90222-1","article-title":"Effect of Highly Purified Porcine Gut Glucagon-Like Immunoreactivity (Glicentin) on Glucose Release From Isolated Rat Hepatocytes","volume":"675","author":"Thieden","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-0028-1092674","article-title":"The Use of Perfused Rat Intestine to Characterise the Glucagon-Like Immunoreactivity Released Into Serosal Secretions Following Stimulation by Glucose","volume":"11","author":"O\u2019Connor","year":"1979","journal-title":"Horm Metab Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90720-b","article-title":"Oxyntomodulin and its (19-37) and (30-37) Fragments Inhibit Histamine-Stimulated Gastric Acid Secretion in the Conscious Rat","volume":"203","author":"Carles-Bonnet","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/297156a0","article-title":"Glicentin Inhibits Gastric Acid Secretion in the Rat","volume":"297","author":"Kirkegaard","year":"1982","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2017.034","article-title":"Insights on Glicentin, a Promising Peptide of the Proglucagon Family","volume":"27","author":"Raffort","year":"2017","journal-title":"Biochem Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1620\/tjem.155.197","article-title":"Effect of Glicentin-Related Peptides Upon the Secretion of Insulin and Glucagon in the Canine Pancreas","volume":"155","author":"Ohneda","year":"1988","journal-title":"Tohoku J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e12638","DOI":"10.14814\/phy2.12638","article-title":"Glicentin-Related Pancreatic Polypeptide Inhibits Glucose-Stimulated Insulin Secretion From the Isolated Pancreas of Adult Male Rats","volume":"3","author":"Whiting","year":"2015","journal-title":"Physiol Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-007-1895-9","article-title":"Glicentin Inhibits Internalization of Enteric Bacteria by Cultured INT-407 Enterocytes","volume":"23","author":"Chiba","year":"2007","journal-title":"Pediatr Surg Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.683089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:23:10Z","timestamp":1623410590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.683089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":49,"alternative-id":["10.3389\/fendo.2021.683089"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.683089","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"article-number":"683089"}}